HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
FPL 55618
RN given refers to parent cpd
Also Known As:
4H-1-Benzopyran-2-carboxylic acid, 5-(3-methylbutoxy)-4-oxo-8-(2-propenyl)-, sodium salt; 5-(3-methylbutoxy)-4-oxo-8-(2-propenyl)-4H-1-benzopyran-2-carboxylic acid, sodium salt; FPL-55618
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyrans: 130
Benzopyrans: 195
Chromones: 159
FPL 55618: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzopyrans: 195
Chromones: 159
FPL 55618: 1
Related Diseases
1.
Right Ventricular Hypertrophy
01/15/1981 - "
Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats.
"
01/15/1981 - "
Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone.
"
2.
Hyperplasia
01/15/1981 - "
Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats.
"
01/15/1981 - "
Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone.
"
3.
Hypoxia (Hypoxemia)
01/15/1981 - "
Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone.
"
Related Drugs and Biologics
1.
Mast Cell Stabilizers